Trials / Unknown
UnknownNCT02149563
Oxygen Therapy in Depression
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Meir Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The major objective of the present study is to examine the influence of normobaric hyperoxia treatment on the symptoms of patients diagnosed with depression members of Clalit Health Services. The investigators hypothesize that normobaric hyperoxia treatment will improve the symptoms of patients with depression.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | oxygen-enriched air -Normobaric hyperoxia treatment for depression | Forty percent oxygen or regular air will be supplied from oxygen concentrators, through standard plastic nasal prongs, at a flow rate of 5 liters/minute, for 7 hours a day, throughout the night. |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2016-04-01
- Completion
- 2016-09-01
- First posted
- 2014-05-29
- Last updated
- 2015-03-17
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT02149563. Inclusion in this directory is not an endorsement.